Stridor Clinical Trials

Find Stridor Clinical Trials Near You

Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Age between 18-45 years

• Both genders (male and female)

• Grade 1-3 on mMRC scale of dyspnea

• Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)

Locations
Other Locations
Pakistan
Foundation University Islamabad
RECRUITING
Islamabad
Contact Information
Primary
Maryam Arooj, MSPT-CPPT
maryamarooj418@gmail.com
+923428190176
Backup
Zara Khalid, PhD
zara.khalid@fui.edu.pk
+92333-5415822
Time Frame
Start Date: 2026-02-28
Estimated Completion Date: 2026-05-15
Participants
Target number of participants: 46
Treatments
Experimental: Alternate Nostril Breathing
Patients in this group will receive Alternate Nostril Breathing (ANB) along with standard pharmacological management as prescribed by the pulmonologist.~The breathing intervention will be performed for a duration of 4 weeks. Two sessions per week will be supervised by a physiotherapist, and five sessions per week will be performed at home. Each session will last 10-15 minutes, following a structured ANB protocol involving slow nasal inhalation and exhalation with brief breath holds.~A home exercise diary will be provided to ensure adherence and follow-up of breathing exercises performed at home.
Experimental: Buteyko Breathing
Patients in this group will receive the Buteyko Breathing Technique (BBT) along with standard pharmacological management as prescribed by the pulmonologist. The intervention will be administered over a period of 4 weeks. Two sessions per week will be supervised by a physiotherapist, while five sessions per week will be carried out at home. Each session will last 10-15 minutes and will include controlled nasal breathing, relaxed exhalation, and breath holding (control pause) until the first sensation of air hunger.~A home diary will be provided to monitor compliance and ensure regular performance of breathing exercises at home.
Related Therapeutic Areas
Sponsors
Leads: Foundation University Islamabad

This content was sourced from clinicaltrials.gov